Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in the Netherlands

Authors: Wim van der Hoek, Jamie CE Meekelenkamp, Alexander CAP Leenders, Nancy Wijers, Daan W Notermans, Chantal WPM Hukkelhoven

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Q fever has become a major public health problem in the Netherlands. Infection with Coxiella burnetii (Q fever) during pregnancy has resulted in adverse pregnancy outcome in the majority of reported cases. Therefore, we aimed to quantify this risk by examining the earliest periods corresponding to the epidemic in the Netherlands.

Methods

Serum samples that had been collected from the area of highest incidence by an existing national prenatal screening programme and data from the Netherlands Perinatal Registry (PRN) on diagnosis and outcome were used. We performed indirect immunofluorescence assay to detect the presence of IgM and IgG antibodies against C. burnetii in the samples. The serological results were analyzed to determine statistical association with recorded pregnancy outcome.

Results

Evaluation of serological results for 1174 women in the PRN indicated that the presence of IgM and IgG antibodies against phase II of C. burnetii was not significantly associated with preterm delivery, low birth weight, or several other outcome measures.

Conclusion

The present population-based study showed no evidence of adverse pregnancy outcome among women who had antibodies to C. burnetii during early pregnancy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schimmer B, Dijkstra F, Vellema P, Schneeberger PM, Hackert V, ter Schegget R, Wijkmans C, van Duynhoven Y, van der Hoek W: Sustained intensive transmission of Q fever in the south of the Netherlands, 2009. Euro Surveill. 2009, 14: 19210-pii,PubMed Schimmer B, Dijkstra F, Vellema P, Schneeberger PM, Hackert V, ter Schegget R, Wijkmans C, van Duynhoven Y, van der Hoek W: Sustained intensive transmission of Q fever in the south of the Netherlands, 2009. Euro Surveill. 2009, 14: 19210-pii,PubMed
2.
go back to reference van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y: Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010, 15: 19520-pii,PubMed van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y: Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010, 15: 19520-pii,PubMed
3.
go back to reference Langley JM, Marrie TJ, Leblanc JC, Almudevar A, Resch L, Raoult D: Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am J Obstet Gynecol. 2003, 189: 228-232. 10.1067/mob.2003.448.CrossRefPubMed Langley JM, Marrie TJ, Leblanc JC, Almudevar A, Resch L, Raoult D: Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am J Obstet Gynecol. 2003, 189: 228-232. 10.1067/mob.2003.448.CrossRefPubMed
4.
go back to reference Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis. 2007, 45: 548-555. 10.1086/520661.CrossRefPubMed Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis. 2007, 45: 548-555. 10.1086/520661.CrossRefPubMed
6.
go back to reference Raoult D, Fenollar F, Stein A: Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. 2002, 162: 701-704. 10.1001/archinte.162.6.701.CrossRefPubMed Raoult D, Fenollar F, Stein A: Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. 2002, 162: 701-704. 10.1001/archinte.162.6.701.CrossRefPubMed
7.
go back to reference Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. 2009, 1166: 79-89. 10.1111/j.1749-6632.2009.04519.x.CrossRefPubMed Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. 2009, 1166: 79-89. 10.1111/j.1749-6632.2009.04519.x.CrossRefPubMed
8.
go back to reference Tissot-Dupont H, Vaillant V, Rey S, Raoult D: Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007, 44: 232-237. 10.1086/510389.CrossRefPubMed Tissot-Dupont H, Vaillant V, Rey S, Raoult D: Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007, 44: 232-237. 10.1086/510389.CrossRefPubMed
9.
go back to reference Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367: 679-688. 10.1016/S0140-6736(06)68266-4.CrossRefPubMed Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367: 679-688. 10.1016/S0140-6736(06)68266-4.CrossRefPubMed
11.
go back to reference Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM: New Dutch reference curves for birthweight by gestational age. Early Hum Dev. 2009, 85: 737-744. 10.1016/j.earlhumdev.2009.09.008.CrossRefPubMed Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM: New Dutch reference curves for birthweight by gestational age. Early Hum Dev. 2009, 85: 737-744. 10.1016/j.earlhumdev.2009.09.008.CrossRefPubMed
12.
go back to reference Netherlands Institute for Social Research: Van hoog naar laag; van laag naar hoog. 1998, Rijswijk, The Netherlands: Sociaal en Cultureel Planbureau, [in Dutch] Netherlands Institute for Social Research: Van hoog naar laag; van laag naar hoog. 1998, Rijswijk, The Netherlands: Sociaal en Cultureel Planbureau, [in Dutch]
13.
go back to reference Netherlands Perinatal Registry (PRN): Perinatal care in the Netherlands 2007. 2009, Utrecht, The Netherlands: PRN Netherlands Perinatal Registry (PRN): Perinatal care in the Netherlands 2007. 2009, Utrecht, The Netherlands: PRN
14.
go back to reference Little RJA: Regression with missing X's: a review. Journal of the American Statistical Association. 1992, 87: 1227-1237. 10.2307/2290664. Little RJA: Regression with missing X's: a review. Journal of the American Statistical Association. 1992, 87: 1227-1237. 10.2307/2290664.
15.
go back to reference Moons KG, Donders RA, Stijnen T, Harrell FE: Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol. 2006, 59: 1092-1101. 10.1016/j.jclinepi.2006.01.009.CrossRefPubMed Moons KG, Donders RA, Stijnen T, Harrell FE: Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol. 2006, 59: 1092-1101. 10.1016/j.jclinepi.2006.01.009.CrossRefPubMed
16.
go back to reference Stein A, Raoult D: Q fever during pregnancy: a public health problem in southern France. Clin Infect Dis. 1998, 27: 592-596. 10.1086/514698.CrossRefPubMed Stein A, Raoult D: Q fever during pregnancy: a public health problem in southern France. Clin Infect Dis. 1998, 27: 592-596. 10.1086/514698.CrossRefPubMed
17.
go back to reference Jover-Díaz F, Robert-Gates J, Andreu-Gimenez L, Merino-Sanchez J: Q fever during pregnancy: an emerging cause of prematurity and abortion. Infect Dis Obstet Gynecol. 2001, 9: 47-49.CrossRefPubMedPubMedCentral Jover-Díaz F, Robert-Gates J, Andreu-Gimenez L, Merino-Sanchez J: Q fever during pregnancy: an emerging cause of prematurity and abortion. Infect Dis Obstet Gynecol. 2001, 9: 47-49.CrossRefPubMedPubMedCentral
18.
go back to reference Denman J, Woods M: Acute Q fever in pregnancy: report and literature review. Intern Med J. 2009, 39: 479-481. 10.1111/j.1445-5994.2009.01933.x.CrossRefPubMed Denman J, Woods M: Acute Q fever in pregnancy: report and literature review. Intern Med J. 2009, 39: 479-481. 10.1111/j.1445-5994.2009.01933.x.CrossRefPubMed
19.
go back to reference Psaroulaki A, Hadjichristodoulou C, Loukaides F, Soteriades E, Konstantinidis A, Papastergiou P, Ioannidou MC, Tselentis Y: Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system. Eur J Clin Microbiol Infect Dis. 2006, 25: 576-586. 10.1007/s10096-006-0170-7.CrossRefPubMed Psaroulaki A, Hadjichristodoulou C, Loukaides F, Soteriades E, Konstantinidis A, Papastergiou P, Ioannidou MC, Tselentis Y: Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system. Eur J Clin Microbiol Infect Dis. 2006, 25: 576-586. 10.1007/s10096-006-0170-7.CrossRefPubMed
20.
go back to reference EFSA Panel on Animal Health and Welfare (AHAW): Scientific opinion on Q fever. EFSA Journal. 2010, 8 (5): 1595-[114 pp.]CrossRef EFSA Panel on Animal Health and Welfare (AHAW): Scientific opinion on Q fever. EFSA Journal. 2010, 8 (5): 1595-[114 pp.]CrossRef
21.
go back to reference Rey D, Obadia Y, Tissot-Dupont H, Raoult D: Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France. Eur J Obstet Gynecol Reprod Biol. 2000, 93: 151-156. 10.1016/S0301-2115(00)00276-1.CrossRefPubMed Rey D, Obadia Y, Tissot-Dupont H, Raoult D: Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France. Eur J Obstet Gynecol Reprod Biol. 2000, 93: 151-156. 10.1016/S0301-2115(00)00276-1.CrossRefPubMed
22.
go back to reference Hunt JG, Field PR, Murphy AM: Immunoglobulin responses to Coxiella burnetii (Q fever): single-serum diagnosis of acute infection, using an immunofluorescence technique. Infect Immun. 1983, 39: 977-981.PubMedPubMedCentral Hunt JG, Field PR, Murphy AM: Immunoglobulin responses to Coxiella burnetii (Q fever): single-serum diagnosis of acute infection, using an immunofluorescence technique. Infect Immun. 1983, 39: 977-981.PubMedPubMedCentral
23.
go back to reference Tissot Dupont H, Thirion X, Raoult D: Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol. 1994, 1: 189-196. Tissot Dupont H, Thirion X, Raoult D: Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol. 1994, 1: 189-196.
24.
go back to reference Villumsen S, Jørgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA: Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis. 2009, 65: 93-98. 10.1016/j.diagmicrobio.2009.06.004.CrossRefPubMed Villumsen S, Jørgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA: Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis. 2009, 65: 93-98. 10.1016/j.diagmicrobio.2009.06.004.CrossRefPubMed
25.
go back to reference Schimmer B, Notermans DW, Harms M, Reimerink JHJ, Bakker J, Schneeberger P, Mollema L, Teunis P, van Pelt W, van Duynhoven Y: Low seroprevalence of Q fever in the Netherlands preceding a series of large outbreaks. Epidemiol Infect. Schimmer B, Notermans DW, Harms M, Reimerink JHJ, Bakker J, Schneeberger P, Mollema L, Teunis P, van Pelt W, van Duynhoven Y: Low seroprevalence of Q fever in the Netherlands preceding a series of large outbreaks. Epidemiol Infect.
26.
go back to reference Fiset P, Wisseman CL, Batawi YE: Immunologic evidence of human foetal infection with Coxiella burnetii. Am J Epidemiol. 1975, 101: 65-69.PubMed Fiset P, Wisseman CL, Batawi YE: Immunologic evidence of human foetal infection with Coxiella burnetii. Am J Epidemiol. 1975, 101: 65-69.PubMed
27.
go back to reference Ludlam H, Wreghitt TG, Thornton S, Thomson BJ, Bishop NJ, Coomber S, Cunniffe J: Q fever in pregnancy. J Infect. 1997, 34: 75-78. 10.1016/S0163-4453(97)80014-X.CrossRefPubMed Ludlam H, Wreghitt TG, Thornton S, Thomson BJ, Bishop NJ, Coomber S, Cunniffe J: Q fever in pregnancy. J Infect. 1997, 34: 75-78. 10.1016/S0163-4453(97)80014-X.CrossRefPubMed
28.
go back to reference Schneeberger PM, Hermans MHA, van Hannen EJ, Schellekens JJA, Leenders ACAP, Wever PC: Real-time PCR on serum samples is indispensable for early diagnosis of acute Q-fever. Clin Vaccine Immunol. 2009 Schneeberger PM, Hermans MHA, van Hannen EJ, Schellekens JJA, Leenders ACAP, Wever PC: Real-time PCR on serum samples is indispensable for early diagnosis of acute Q-fever. Clin Vaccine Immunol. 2009
29.
go back to reference van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, Notermans DW, Schneeberger PM: Three years of Q fever in the Netherlands: faster diagnosis. Ned Tijdschr Geneeskd. 2010, 154: A1845-[in Dutch]PubMed van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, Notermans DW, Schneeberger PM: Three years of Q fever in the Netherlands: faster diagnosis. Ned Tijdschr Geneeskd. 2010, 154: A1845-[in Dutch]PubMed
30.
go back to reference Munster JM, Leenders ACAP, Van der Hoek W, Schneeberger PM, Rietveld A, Riphagen-Dalhuisen J, Stolk RP, Hamilton CJCM, De Vries E, Meekelenkamp J, Lo-Ten-Foe JR, Timmer A, De Jong-van den Berg LTW, Aarnoudse JG, Hak E: Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Womens Health. 10: 32-10.1186/1472-6874-10-32. Munster JM, Leenders ACAP, Van der Hoek W, Schneeberger PM, Rietveld A, Riphagen-Dalhuisen J, Stolk RP, Hamilton CJCM, De Vries E, Meekelenkamp J, Lo-Ten-Foe JR, Timmer A, De Jong-van den Berg LTW, Aarnoudse JG, Hak E: Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Womens Health. 10: 32-10.1186/1472-6874-10-32.
Metadata
Title
Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in the Netherlands
Authors
Wim van der Hoek
Jamie CE Meekelenkamp
Alexander CAP Leenders
Nancy Wijers
Daan W Notermans
Chantal WPM Hukkelhoven
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-44

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.